Sutib Tablet 12.5 mg contains Sunitinib, an oral multitargeted receptor tyrosine kinase inhibitor used in cancer therapy. It works by inhibiting specific enzymes that promote tumor growth and blood vessel formation (angiogenesis), thereby slowing cancer progression. Sutib 12.5 mg is commonly used in the treatment of renal cell carcinoma, gastrointestinal stromal tumors (GIST), and other advanced or metastatic solid tumors.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Uses and Benefits

• Renal Cell Carcinoma (RCC): Used in patients with advanced kidney cancer to slow tumor growth and progression.

• Gastrointestinal Stromal Tumors (GIST): Effective in treating GIST in patients who are resistant to or intolerant of imatinib therapy.

• Pancreatic Neuroendocrine Tumors (pNET): Helps manage advanced pancreatic neuroendocrine tumors, improving disease control.

• Targeted Cancer Therapy: Sunitinib selectively inhibits tyrosine kinases involved in tumor proliferation and angiogenesis, reducing tumor vascularization and growth.

• Oral Administration: Convenient once-daily oral dosing improves adherence for patients requiring long-term treatment.

Mechanism of Action

Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), including:

• VEGFR (Vascular Endothelial Growth Factor Receptor) – prevents formation of new blood vessels in tumors.

• PDGFR (Platelet-Derived Growth Factor Receptor) – disrupts signaling that supports tumor growth.

• KIT, FLT3, RET – involved in tumor cell proliferation and survival.

By blocking these pathways, Sunitinib reduces tumor blood supply, inhibits growth, and induces apoptosis in cancer cells.

Dosage and Administration

• Administration: Take orally with or without food. Swallow the tablet whole; do not crush or chew.

• Dosage: The typical starting dose varies according to the type of cancer, patient condition, and tolerance. The 12.5 mg strength is often used for dose adjustments in patients who experience side effects or require titration.

• Cycle: Usually administered once daily for a specific number of weeks followed by a rest period, as per oncologist’s instructions.

• Monitoring: Regular blood tests, blood pressure checks, and cardiac monitoring are essential during treatment.

Precautions and Safety Information

• Medical History: Inform your doctor if you have liver or kidney impairment, heart disease, bleeding disorders, or hypertension.

• Pregnancy and Lactation: Contraindicated; effective contraception is necessary for both men and women during treatment.

• Drug Interactions: Avoid strong CYP3A4 inhibitors or inducers unless directed by your physician.

• Activity Caution: May cause fatigue, dizziness, or visual disturbances. Take care when driving or operating machinery.

Possible Side Effects

Sutib Tablet 12.5 mg may cause:

• Fatigue, weakness, or headache

• Nausea, vomiting, or diarrhea

• Hypertension or palpitations

• Skin changes, hand-foot syndrome, or rash

• Rarely, liver enzyme elevation, bleeding, or heart complications

Most side effects are manageable with dose adjustments and close medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a cool, dry place.

• Keep tablets in the original packaging to protect from moisture and light.

• Keep out of reach of children.

Sutib Tablet 12.5 mg is an effective, oral targeted therapy for managing various advanced cancers. When used under careful medical supervision, it helps slow tumor growth, control disease progression, and improve patient outcomes.